At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A Co-administered With Zilbrix™ Hib and Polio Sabin™
In Brief
A Phase 3 clinical trial evaluating GSK Biologicals' Synflorix™, GSK Biologicals' Polio Sabin™, and 1 other intervention for Infections, Streptococcal. Completed, enrolled 365 participants across 2 sites in 2 countries.
Detailed Summary
The purpose of this study is to assess the immunogenicity in terms of antibody response and the safety/reactogenicity in terms of solicited and unsolicited symptoms and serious adverse events following primary vaccination of African Sub-Saharan infants with pneumococcal conjugate vaccine GSK 1024850A co-administered with a diphtheria, tetanus, whole cell pertussis (DTPw)-combined vaccine and oral polio vaccine in children during the first 4 months of life.
Study Details
Timeline
Interventions
3 IM doses.
3 oral doses
3 IM doses.